bioMerieux SA (BIM) - Product Pipeline Analysis, 2020 Update



bioMerieux SA (bioMerieux), a subsidiary of Institut Merieux SA, develops, manufactures, and markets in vitro diagnostic solutions for hospital and private laboratories. The company offers diagnostic solutions such as systems, reagents, and software for the diagnosis of infectious diseases, cardiovascular diseases, and cancers and identifying microorganisms in pharmaceuticals, cosmetics, and agri-food products. It offers microbiology products, immunoassays, molecular biology tests, and other solutions for clinical applications and industrial microbiological control solutions for the food, biopharmaceutical and cosmetics industries; veterinary diagnostic laboratories; and blood banks. bioMerieux also provides solutions for the enumeration of bacterial flora which indicate the quality of food products. The company distributes its products directly and also through a network of distributors across the world. bioMerieux is headquartered in Marcy lEtoile, France.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company bioMerieux SA
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company




bioMerieux SA Company Overview
bioMerieux SA Company Snapshot
bioMerieux SA Pipeline Products and Ongoing Clinical Trials Overview
bioMerieux SA Pipeline Analysis Overview
Business Description
bioMerieux SA - Key Facts
bioMerieux SA - Major Products and Services
bioMerieux SA Pipeline Products by Development Stage
bioMerieux SA Ongoing Clinical Trials by Trial Status
bioMerieux SA Pipeline Products Overview
Annexin A3 Prostate Cancer Marker
Annexin A3 Prostate Cancer Marker Product Overview
ARGENE SARS-COV-2 R-GENE Test
ARGENE SARS-COV-2 R-GENE Test Product Overview
Biomarker Test - Chronic Q Fever
Biomarker Test - Chronic Q Fever Product Overview
BRAF - Breast Cancer Diagnostic Kit
BRAF - Breast Cancer Diagnostic Kit Product Overview
CancerTARGET ID
CancerTARGET ID Product Overview
CancerTREATMENT ID
CancerTREATMENT ID Product Overview
Companion Diagnostic Test - Hormone-Dependent Breast Cancer
Companion Diagnostic Test - Hormone-Dependent Breast Cancer Product Overview
Companion Diagnostic Test - Hormone-Dependent Neuro Endocrine Tumor
Companion Diagnostic Test - Hormone-Dependent Neuro Endocrine Tumor Product Overview
Companion Diagnostic Test - Hormone-Dependent Pituitary Tumor
Companion Diagnostic Test - Hormone-Dependent Pituitary Tumor Product Overview
Companion Diagnostic Test - Hormone-Dependent Prostate Cancer
Companion Diagnostic Test - Hormone-Dependent Prostate Cancer Product Overview
Diagnostic Assay - Prostate Cancer
Diagnostic Assay - Prostate Cancer Product Overview
Diagnostic Test - Abdominal Pain
Diagnostic Test - Abdominal Pain Product Overview
Diagnostic Test - Acute Coronary Syndrome
Diagnostic Test - Acute Coronary Syndrome Product Overview
Diagnostic Test - Acute Respiratory Infection
Diagnostic Test - Acute Respiratory Infection Product Overview
Diagnostic Test - Antimicrobial Resistance
Diagnostic Test - Antimicrobial Resistance Product Overview
Diagnostic Test - Cerebrovascular Injury
Diagnostic Test - Cerebrovascular Injury Product Overview
Diagnostic Test - Sepsis
Diagnostic Test - Sepsis Product Overview
Diagnostic Test - Tuberculosis
Diagnostic Test - Tuberculosis Product Overview
FilmArray 2.0 - Lower Respiratory Tract Panel
FilmArray 2.0 - Lower Respiratory Tract Panel Product Overview
FilmArray 2.0 - Lower Respiratory Tract Panel Clinical Trial
FilmArray Febrile Infant Panel
FilmArray Febrile Infant Panel Product Overview
FilmArray Sepsis Direct Panel
FilmArray Sepsis Direct Panel Product Overview
FilmArray STD Panel
FilmArray STD Panel Product Overview
iMAG
iMAG Product Overview
NucliSENS EasyQ Chlamydia Pneumoniae Molecular Test
NucliSENS EasyQ Chlamydia Pneumoniae Molecular Test Product Overview
NucliSENS EasyQ Legionella spp Molecular Test
NucliSENS EasyQ Legionella spp Molecular Test Product Overview
NucliSENS EasyQ Mycoplasma Pneumoniae Molecular Test
NucliSENS EasyQ Mycoplasma Pneumoniae Molecular Test Product Overview
VIDAS hsCRP Assay
VIDAS hsCRP Assay Product Overview
Vidas Immunoanalyzer - Nephrocheck
Vidas Immunoanalyzer - Nephrocheck Product Overview
bioMerieux SA - Key Competitors
bioMerieux SA - Key Employees
bioMerieux SA - Key Employee Biographies
bioMerieux SA - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
bioMerieux SA, Recent Developments
Jun 02, 2020: Teklynx labeling software teklynx central increases labeling accuracy & compliance by 100% for global biotechnology company bioMerieux
Mar 31, 2020: AdvaMed: COVID-19 test availability rapidly scales up
Mar 12, 2020: Covid-19: BioMerieux launches three coronavirus tests
Feb 26, 2020: bioMerieux 2019 financial results
Feb 24, 2020: Biotheranostics pivotal clinical study of the Breast Cancer Index featured on the cover of the Annals of Oncology
Jan 14, 2020: bioMerieux submits enhanced BIOFIRE BCID2 panel for FDA clearance
Dec 11, 2019: Biotheranostics launches Not Another Minute Campaign for its Breast Cancer Index test
Oct 22, 2019: bioMerieux Third quarter 2019 business review
Sep 05, 2019: Breast Cancer Index publishes new pivotal data strengthening clinical evidence as a predictive factor of benefit from endocrine therapy
Sep 04, 2019: bioMerieux announces First-Half 2019 Results
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables


bioMerieux SA Pipeline Products and Ongoing Clinical Trials Overview
bioMerieux SA Pipeline Products by Equipment Type
bioMerieux SA Pipeline Products by Indication
bioMerieux SA Ongoing Clinical Trials by Trial Status
bioMerieux SA, Key Facts
bioMerieux SA, Major Products and Services
bioMerieux SA Number of Pipeline Products by Development Stage
bioMerieux SA Pipeline Products Summary by Development Stage
bioMerieux SA Ongoing Clinical Trials by Trial Status
bioMerieux SA Ongoing Clinical Trials Summary
Annexin A3 Prostate Cancer Marker - Product Status
Annexin A3 Prostate Cancer Marker - Product Description
ARGENE SARS-COV-2 R-GENE Test - Product Status
ARGENE SARS-COV-2 R-GENE Test - Product Description
Biomarker Test - Chronic Q Fever - Product Status
Biomarker Test - Chronic Q Fever - Product Description
BRAF - Breast Cancer Diagnostic Kit - Product Status
BRAF - Breast Cancer Diagnostic Kit - Product Description
CancerTARGET ID - Product Status
CancerTARGET ID - Product Description
CancerTREATMENT ID - Product Status
CancerTREATMENT ID - Product Description
Companion Diagnostic Test - Hormone-Dependent Breast Cancer - Product Status
Companion Diagnostic Test - Hormone-Dependent Breast Cancer - Product Description
Companion Diagnostic Test - Hormone-Dependent Neuro Endocrine Tumor - Product Status
Companion Diagnostic Test - Hormone-Dependent Neuro Endocrine Tumor - Product Description
Companion Diagnostic Test - Hormone-Dependent Pituitary Tumor - Product Status
Companion Diagnostic Test - Hormone-Dependent Pituitary Tumor - Product Description
Companion Diagnostic Test - Hormone-Dependent Prostate Cancer - Product Status
Companion Diagnostic Test - Hormone-Dependent Prostate Cancer - Product Description
Diagnostic Assay - Prostate Cancer - Product Status
Diagnostic Assay - Prostate Cancer - Product Description
Diagnostic Test - Abdominal Pain - Product Status
Diagnostic Test - Abdominal Pain - Product Description
Diagnostic Test - Acute Coronary Syndrome - Product Status
Diagnostic Test - Acute Coronary Syndrome - Product Description
Diagnostic Test - Acute Respiratory Infection - Product Status
Diagnostic Test - Acute Respiratory Infection - Product Description
Diagnostic Test - Antimicrobial Resistance - Product Status
Diagnostic Test - Antimicrobial Resistance - Product Description
Diagnostic Test - Cerebrovascular Injury - Product Status
Diagnostic Test - Cerebrovascular Injury - Product Description
Diagnostic Test - Sepsis - Product Status
Diagnostic Test - Sepsis - Product Description
Diagnostic Test - Tuberculosis - Product Status
Diagnostic Test - Tuberculosis - Product Description
FilmArray 2.0 - Lower Respiratory Tract Panel - Product Status
FilmArray 2.0 - Lower Respiratory Tract Panel - Product Description
FilmArray 2.0 - Lower Respiratory Tract Panel - Projected Influence of Enhanced Pathogen Detection on the Clinical Management of Community-acquired Pneumonia
FilmArray Febrile Infant Panel - Product Status
FilmArray Febrile Infant Panel - Product Description
FilmArray Sepsis Direct Panel - Product Status
FilmArray Sepsis Direct Panel - Product Description
FilmArray STD Panel - Product Status
FilmArray STD Panel - Product Description
iMAG - Product Status
iMAG - Product Description
NucliSENS EasyQ Chlamydia Pneumoniae Molecular Test - Product Status
NucliSENS EasyQ Chlamydia Pneumoniae Molecular Test - Product Description
NucliSENS EasyQ Legionella spp Molecular Test - Product Status
NucliSENS EasyQ Legionella spp Molecular Test - Product Description
NucliSENS EasyQ Mycoplasma Pneumoniae Molecular Test - Product Status
NucliSENS EasyQ Mycoplasma Pneumoniae Molecular Test - Product Description
VIDAS hsCRP Assay - Product Status
VIDAS hsCRP Assay - Product Description
Vidas Immunoanalyzer - Nephrocheck - Product Status
Vidas Immunoanalyzer - Nephrocheck - Product Description
bioMerieux SA, Key Employees
bioMerieux SA, Key Employee Biographies
bioMerieux SA, Subsidiaries
Glossary

List Of Figures


bioMerieux SA Pipeline Products by Equipment Type
bioMerieux SA Pipeline Products by Development Stage
bioMerieux SA Ongoing Clinical Trials by Trial Status

bioMerieux SA (BIM) - Product Pipeline Analysis, 2019 Update

bioMerieux SA (bioMerieux), a subsidiary of Institut Merieux SA, develops, manufactures, and markets in vitro diagnostic solutions for hospital and private laboratories. The company offers diagnostic solutions such as systems,

USD 750 View Report

bioMerieux SA (BIM) - Product Pipeline Analysis, 2019 Update

bioMerieux SA (bioMerieux), a subsidiary of Institut Merieux SA, develops, manufactures, and markets in vitro diagnostic solutions for hospital and private laboratories. The company offers diagnostic solutions such as systems,

USD 750 View Report

bioMerieux SA. - Strategy, SWOT and Corporate Finance Report

bioMerieux SA. - Strategy, SWOT and Corporate Finance ReportbioMerieux SA. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the

USD 175 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available